Patent · US Expired

Plant bioreactors

US7361331B2 · kind B2 · utility

3Cited by
22References
18Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 3, 2002
Grant dateApr 22, 2008
Priority date
Expiry dateMay 3, 2022

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N15/8273
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A plant expressing a cytokine and an autoantigen is disclosed. An example of a cytokine is a contra-inflammatory cytokine, for example IL-4 and IL-10, and an example of autoantigen is GAD. A novel method for the production of transgenic proteins of interest suitable for oral administration is also disclosed. Further, non-food crop plants expressing one or more proteins of interest are disclosed, as is a method involving the preparation of a protein of interest suitable for oral administration within a non-food crop plant comprising, transforming the non-food crop plant with a suitable vector containing a gene of interest and appropriate regulatory regions to ensure expression of the gene of interest within the non-food crop plant, such that the non-food crop plant is characterized as being non-toxic, non-addictive, palatable, and requiring minimal or no processing prior to oral administration. An example of a non-food crop plant is low alkaloid tobacco. Proteins of interest may include pharmaceutically active proteins such as growth regulators, insulin, interferons, interleukins, growth hormone, erythropoietin, G-CSF, GM-CSF, hPG-CSF, M-CSF, Factor VIII, Factor IX, tPA, antibodies,…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.